Biohit Plc - Managers' transactions - Aiolfi

Notifying Person

Name: Euroclone SpA

Position: Closely associated person

(X) Legal Person

(1): Associated Person

Name: Aiolfi, Franco

Position: Member of the Board

Issuer name: Biohit Plc

LEI: 74370089ATTSNBXJVT29

Notification Type: INITIAL NOTIFICATION

Notification reference: 74370089ATTSNBXJVT29_20200131170019_3

____________________________________________

Transaction date: 2020-01-28

Transaction place not applicable

Instrument: SHARE

ISIN: FI0009005482

Nature of transaction: OTHER

Description of transaction:

Transfer of shares from Franco Aiolfi’s previously managed and controlled Euroclone SpA to Franco Aiolfi’s managed and controlled BioAir SpA

Transaction details

(1): Volume: 92 807 Price:  EUR

Aggregated Information

(1): Volume: 92 807 Average Price:  EUR

Additional information:

CEO Semi Korpela, Biohit Oyj

tel. +358 9 773 861

investor.relations@biohit.fi

www.biohithealthcare.com

Biohit Oyj in brief

Biohit Oyj is a globally operating Finnish biotechnology company. Biohit’s mission ‘Innovating for Health’ means that we provide innovative products and services to promote research and early diagnostics. Biohit is headquartered in Helsinki and has subsidiaries in Italy and the UK. Biohit’s B series shares (BIOBV) are quoted on NASDAQ OMX Helsinki under Small cap/Healthcare. www.biohithealthcare.com